References
- Savage C OS, Ng Y C. The etiology and pathogenesis of major systemic vasculitis. Postgrad Med J 1986; 62: 621–636
- Pober J S., Gimbrone M A, Jr., Cotran R S., Reiss C S, Burakoff S J., Fiers W, Ault K A. la expression of vascular endothelium is inducible by activated T cells and by gamma interferon. J. ESP Med 1983; 157: 1339–1353
- Norioka K, Hard M, Kitani A, Hirose T, Hirose W, Harigai M, Suzuki K, et al. Inhibitory effect of human interleukin-lα and β on growth of human vascular endothelial cells. Biochem Biophys Res Commun 1987; 145: 969–975
- Cavender E C, Haskard D O, Joseph B, Ziff M. lnterleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers. J Immunol 1986; 136: 203–207
- Albrightson C R, Baenziger N L, Needleman P. Exaggerated human vascular cell prostaglandine biosynthesis mediated by monocytes: role of monokines and interleukin I. J Immunol 1985; 135: 1872–1877
- Hirano T, Taga T, Nakano N, Yasukawa K, Kashimura S, Shimizu K, et al. Purification to homogeneity and characterization of human B-cell differentiation factor. Proe Nat Acad Sci USA 1985; 82: 5490–5494
- Sehgal P B, May L T, Tamm I, Vilcek J. Human β2 Interferon and B-cell differentiation factor BSF-2 are Identical. Science 1987; 235: 731–732
- Norioka K, Hara M, Harigai M, Kitani A, Hirose T, Suzuki K, Kawakami M, et al. Production of B cell stimulatory factor-2/interleukin-6 activity by human endothelial cells. Biochem Biophys Res Commun 1988; 153: 1045–1050
- Miossec P, Cavender D, Ziff M. Production of interleukin 1 by human endothelial cells. J lmmunol 1986; 136: 2486–2491
- Jonasson L, Holm J, Skalli O, Gabbiani G, Hansson G K. Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J Clin Invest 1985; 76: 125–131
- Libby P, Ordocas J M, Birinyi L K, Auger K R, Dinarello C A. Inducible interleukin-I expression in human vascular smooth muscle cells. J Clin Invest 1986; 78: 1432–1438
- Norioka K. Stimulatory effect of IL-lα on the IL-6 production by vascular cells. J Keio Med Soc (in Japanese) 1989; 66: 977–986
- Hirano T, Matsuda T, Hosoi K, Okano A, Matsui H, Kishimoto T. Absence of antiviral activity in recombinant B cell stimulatory factor 2(BSF-2). Immunol Lett 1988; 17: 41–45
- Chamley-Campbell J, Campbell G R, Ross R. The smooth muscle in culture. Physiol Rev 1979; 59: 1–61
- Chamley J H, Groschel-Stewart U, Campbell G R, Burnstock G. Distinction between smooth muscle, fibroblasts and endothelial cells in culture by use of fluoresceinated antibodies against smooth muscle actin. Cell Tissue Res 1977; 177: 445–457
- Voyta J C, David P V, Butterfield C E, Zetter B R. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J Cell Biol 1984; 99: 2034–2040
- Jaffe E A, Nachman E R, Becker C, Minic C. Cultures of human endothelial ceils derived from umbilical veins. J Clin Invest 1973; 52: 2745–2756
- Matsuda T, Hirano T, Kishimoto T. Establishment of an interleukin 6 (IL6)/B cell stimulatory factor (BSF)-2-dependent cell line and preparation of anti-IL6-BSF-2 monoclonal antibodies. Eur J Immunol 1988; 18: 951–956
- Hirose T, Hara M, Kitani A, Hirose W, Norioka K, Kawagoe M, Nakamura H. Abnormal production of and response to B-cell growth factors and B-cell differentiation factor in patients with systemic lupus erythematosus. Scand J Immunol 1985; 21: 141–150
- Lansdorp P M, Arden L A, Calafat J, Zeiljemaker W P. A growth-factor dependent B-cell hybridoma. Curren. Topics Microbiol Immunol 1986; 132: 105–113
- Sehgal P B, Walther Z, Tamm I. Rapid enhancement of β2-interferon/B-ceIl differentiation factor BSF-2 gene expression in human fibroblasts by diacylglycerols and calcium ionophore A23187. Proe Nat Acad Sci USA 1987; 84: 3663–3667
- Libby P, Warner S JC, Friedman G B. Interleukin-I: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest 1988; 81: 487–498
- Raines E W, Dower S K, Ross R. Interleukin-I mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science 1989; 243: 393–396
- Oppenheim J J, Kovacs E J, Matsushima K, Durum S K. There is more than one interleukin I. Immunol Today 1986; 7: 45–56
- Gauldie J, Richards C, Harnish D, Lansdorp P, Baumann H. Interferon β2 /B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Nat Acad Sci USA 1987; 84: 7251–7255
- Houssiau F A, Devogelaer J-P, Van Damme J, Deuxchaisnes C N, Van Snick J. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arth Rheum 1988; 31: 784–788
- Hirano T, Taga T, Yasukawa K, Nakajima K, Nakano N, Takatuki F, et al. Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production. Proc Nat Acad Sci USA 1987; 84: 228–231
- Matsushima K, Taguchi M, Kovacs E J, Young H A, Oppenheim J J. Intracellular localization of human monocyte associated interleukin-I activity and release of biologically active IL-1 from monocytes by trypsin and plasmin. J Immunol 1986; 136: 2883–2891